British diabetic association guidelines on genetic and immune screening for Type 1 diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 8, 1998, Pages 643-

  Avery, L ^a   Borsey, D Q ^a   Greene, S A ^a   Gummerson, I ^a   Hayes, R ^a   Kerr, D ^a   Lean, M E J ^a   Marshall, S M ^a   McInnes, A ^a   Pierce, M ^a   Roland, J ^a   Sinclair, A J ^a   Tadman, J ^a   Walton, A ^a   Wiles, P ^a  

^a Tower Hamlets Primary Care Trust   (United Kingdom)

Author keywords

Genetic abnormalities; Immune markers; Immune modulation; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN; INSULIN; INSULIN ANTIBODY; NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; AUTOIMMUNITY; GENETIC SCREENING; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; UNITED KINGDOM;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; GENETIC SCREENING; GREAT BRITAIN; HUMANS; MASS SCREENING; NUCLEAR FAMILY; RISK FACTORS;

EID: 0031845421     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199808)15:8<643::AID-DIA647>3.0.CO;2-6     Document Type: Article

References (0)